PMID: 11331213May 2, 2001Paper

Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study

European Journal of Endocrinology
D GlinoerBelgian Collaborative Study Group on Graves' Disease

Abstract

In Graves' hyperthyroidism treated with antithyroid drugs (ATD), the overall relapse rate reaches 30-50% following ATD discontinuation. Conflicting results have previously been reported with regard to the usefulness of combining ATD with thyroxine (l-T4), and thereafter maintaining l-T4 treatment after ATD withdrawal. Also, clinicians are in search of useful parameters to predict the risk of a recurrence of hyperthyroidism after ATD treatment. Eighty-two consecutive patients (70 women and 12 men; mean age 36 years) with a first episode of Graves' hyperthyroidism were investigated prospectively; they were treated with ATD for a total of 15 months, combined with l-T4 (for at least 12 months) after they had reached euthyroidism, with the aim of maintaining serum TSH below 2.5 mU/l during the combined therapy. Following ATD discontinuation, the patients were randomly assigned (double-blind placebo-controlled trial) to taking 100 microg/day l-T4 (vs placebo) for an additional year. The following determinations were carried out at initial diagnosis: serum total T4 and tri-iodothyronine (T3), free T4 and T3, TSH, TSH-receptor antibodies (TSHR-Ab), thyroid scintigraphy and echography. During ATD treatment, serum free T4 and T3 and TSH ...Continue Reading

Citations

Aug 7, 2002·Trends in Endocrinology and Metabolism : TEM·Wilmar M Wiersinga, Mark F Prummel
Feb 21, 2003·Thyroid : Official Journal of the American Thyroid Association·Rudolf HoermannUNKNOWN Basedow Study Group
Dec 19, 2002·Thyroid : Official Journal of the American Thyroid Association·Jacques Orgiazzi, Anne-Marie Madec
Dec 19, 2002·Thyroid : Official Journal of the American Thyroid Association·Wilmar M Wiersinga, Luigi Bartalena
Sep 29, 2005·Thyroid : Official Journal of the American Thyroid Association·Beate QuadbeckUNKNOWN Basedow Study Group
Aug 13, 2011·Thyroid : Official Journal of the American Thyroid Association·Peter LaurbergInge Bülow Pedersen
Feb 20, 2010·Therapeutics and Clinical Risk Management·Prakash Abraham, Shamasunder Acharya
May 29, 2004·Journal of Endocrinological Investigation·L HegediüsP Vestergaard
May 31, 2002·Journal of Endocrinological Investigation·Luigi Bartalena
Sep 29, 2005·European Journal of Endocrinology·Prakash AbrahamJohn S Bevan
Dec 25, 2013·European Journal of Endocrinology·Eric MohlinMats Eliasson
Apr 23, 2011·Thyroid : Official Journal of the American Thyroid Association·Rebecca S Bahn ChairUNKNOWN American Association of Clinical Endocrinologists
Aug 19, 2008·Wiener klinische Wochenschrift·Christian BieglmayerWolfgang Zechmann
Dec 26, 2009·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Antoine DigonnetGuy Andry
Apr 13, 2010·Der Internist·A Eckstein, J Esser
Sep 26, 2008·The New England Journal of Medicine·Martin A WalterBeat Muller
Sep 20, 2005·Orbit·Wilmar M Wiersinga
Jun 15, 2005·Expert Opinion on Pharmacotherapy·Luigi BartalenaEnio Martino
Mar 8, 2012·Disability and Rehabilitation·Milisav CutovicVladislava Vesovic-Potic
May 29, 2012·Best Practice & Research. Clinical Endocrinology & Metabolism·Luigi Bartalena
Dec 17, 2009·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Toshiki NagasakiYoshiki Nishizawa
Apr 16, 2013·Clinical Endocrinology·Wilmar M Wiersinga
May 18, 2004·The Surgical Clinics of North America·Elizabeth N Pearce, Lewis E Braverman
Jun 20, 2016·Journal of Endocrinological Investigation·L BartalenaP Vitti
Sep 13, 2016·Expert Opinion on Pharmacotherapy·Onyebuchi E Okosieme, John H Lazarus
Oct 27, 2016·European Journal of Endocrinology·Tristan StrujaPhilipp Schuetz
May 2, 2017·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Hyun Joo KimWon Woo Lee
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Prakash AbrahamJohn S Bevan
Oct 19, 2017·Thyroid : Official Journal of the American Thyroid Association·Koshi HashimotoYoshihiro Ogawa
Oct 16, 2018·European Journal of Endocrinology·Henry B Burch, David S Cooper
Jun 18, 2005·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Adel Alnaqdy, Masoud Al-Maskari
Aug 12, 2014·Current Opinion in Endocrinology, Diabetes, and Obesity·Peter LaurbergStine Linding Andersen
Dec 23, 2019·The Journal of Clinical Endocrinology and Metabolism·George J KahalyPaul D Olivo
Jul 31, 2008·The Journal of Clinical Endocrinology and Metabolism·Mario RotondiLuca Chiovato
May 10, 2017·Endocrine·Y S HussainS P Balasubramanian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.